Dose-dependent effects of olanzapine on QT intervals and plasma prolactin levels in Japanese patients with stable schizophrenia

Human Psychopharmacology

Volumn 26, Issue 6, 2011, Pages 440-443

  Suzuki, Yutaro ^a   Ono, Shin ^a   Sugai, Takuro ^a   Fukui, Naoki ^a   Watanabe, Junzo ^a   Tsuneyama, Nobuto ^a   Sawamura, Kazushi ^a   Someya, Toshiyuki ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

dose effect; olanzapine; prolactin; QT interval; side effect

Indexed keywords

CHOLESTEROL; ELECTROLYTE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OLANZAPINE; PROLACTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BRIEF PSYCHIATRIC RATING SCALE; CHOLESTEROL BILE LEVEL; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; JAPANESE; MALE; MENTAL PATIENT; PLASMA; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; QT INTERVAL; SCHIZOPHRENIA; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BODY MASS INDEX; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; JAPAN; LONG QT SYNDROME; MALE; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 80052265884     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1218     Document Type: Article

References (15)

1. Dineen S, Withrow K, Voronovitch L, Munshi F, Nawbary MW, Lippmann S,. 2003. QTc prolongation and high-dose olanzapine. Psychosomatics 44: 174-175.
2. Fraguas D, Correll CU, Merchán-Naranjo J, et al., 2011. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons. Eur Neuropsychopharmacol 21: 621-45.
3. Glassman AH, Bigger JT,. 2001. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 158: 1774-82. (Pubitemid 33054769)
4. Goldenberg I, Moss AJ, Zareba W,. 2006. QT interval: how to measure it and what is "normal". J Cardiovasc Electrophysiol 17: 333-336. (Pubitemid 43344951)
5. Gurovich I, Vempaty A, Lippmann S,. 2003. QTc prolongation: chlorpromazine and high-dosage olanzapine. Can J Psychiatry 48: 348. (Pubitemid 36841275)
6. Haddad PM, Wieck A,. 2004. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs 64: 2291-314. (Pubitemid 39388605)
7. Kinon BJ, Volavka J, Stauffer V, et al,. 2008. Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study. J Clin Psychopharmacol 28: 392-400.
8. Kleinberg DL, Davis JM, de Coster R, Van Baelen B, Brecher M,. 1999. Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychopharmacol 19: 57-61. (Pubitemid 29047332)
9. Knegtering R, Baselmans P, Castelein S, Bosker F, Bruggeman R, van den Bosch RJ,. 2005. Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels. Am J Psychiatry 162: 1010-1012. (Pubitemid 40676220)
10. Lim KS, Jang IJ, Kim BH, et al,. 2010. Changes in the QTc interval after administration of flecainide acetate, with and without coadministered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects. Clin Ther 32: 659-666.
11. Marken PA, Haykal RF, Fisher JN,. 1992. Management of psychotropic-induced hyperprolactinemia. Clin Pharm 11: 851-856.
12. Melkersson KI,. 2006. Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite. Hum Psychopharmacol 21: 529-532. (Pubitemid 46062141)
13. Sawamura K, Suzuki Y, Fukui N, Sugai T, Someya T,. 2006. Gender differences in prolactin elevation induced by olanzapine in Japanese drug-naïve schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 30: 1511-1154.
14. Su KP, Lane HY, Chuang CL, Chen KP, Shen WW,. 2004. Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome. Schizophr Res 66: 191-192. (Pubitemid 38041120)
15. Tran H, White CM, Chow MS, Kluger J,. 2001. An evaluation of the impact of gender and age on QT dispersion in healthy subjects. Ann Noninvasive Electrocardiol 6: 129-133. (Pubitemid 32423399)